Subsite-based alterations in miR-21, miR-125b, and miR-203 in squamous cell carcinoma of the oral cavity and correlation to important target proteins
Open Access
- 1 January 2012
- journal article
- Published by Medknow in Journal of Carcinogenesis
- Vol. 11 (1), 19
- https://doi.org/10.4103/1477-3163.104007
Abstract
MicroRNAs (miRNAs) are small noncoding RNA molecules with an essential role in regulation of gene expression. miRNA expression profiles differ between tumor and normal control tissue in many types of cancers and miRNA profiling is seen as a promising field for finding new diagnostic and prognostic tools. In this study, we have analyzed expression of three miRNAs, miR-21, miR-125b, and miR-203, and their potential target proteins p53 and p63, known to be deregulated in squamous cell carcinoma of the head and neck (SCCHN), in two distinct and one mixed subsite in squamous cell carcinoma in the oral cavity. We demonstrate that levels of miRNA differ between tumors of different subsites with tongue tumors showing significant deregulation of all three miRNAs, whereas gingival tumors only showed significant downregulation of miR-125b and the mixed group of tumors in tongue/floor of the mouth showed significant deregulation of miR-21 and miR-125b. In the whole group of oral squamous cell carcinoma (SCC), a significant negative correlation was seen between miR-125b and p53 as well as a significant correlation between TP53 mutation status and miR-125b. The present data once again emphasize the need to take subsite into consideration when analyzing oral SCC and clearly show that data from in vitro studies cannot be transferred directly to the in vivo situation.Keywords
This publication has 42 references indexed in Scilit:
- Retrospective study of survival and treatment pattern in a cohort of patients with oral and oropharyngeal tongue cancers from 1987 to 2004Oral Oncology, 2007
- p63 overexpression associates with poor prognosis in head and neck squamous cell carcinomaHuman Pathology, 2005
- Dominant Negative p63 Isoform Expression in Head and Neck Squamous Cell CarcinomaThe Laryngoscope, 2004
- Complex p63 mRNA isoform expression patterns in squamous cell carcinoma of the head and neck.International Journal of Oncology, 2004
- Expression of p53 and its homologues in primary and recurrent squamous cell carcinomas of the head and neckInternational Journal of Cancer, 2002
- p63 and p73: p53 mimics, menaces and moreNature Reviews Molecular Cell Biology, 2000
- The p53 molecule and its prognostic role in squamous cell carcinomas of the head and neckJournal of Oral Pathology & Medicine, 2000
- AIS is an oncogene amplified in squamous cell carcinomaProceedings of the National Academy of Sciences, 2000
- p63, a p53 Homolog at 3q27–29, Encodes Multiple Products with Transactivating, Death-Inducing, and Dominant-Negative ActivitiesMolecular Cell, 1998
- Distinct patterns of chromosomal alterations in high- and low-grade head and neck squamous cell carcinomas.1996